-+ 0.00%
-+ 0.00%
-+ 0.00%

HC Wainwright & Co. Initiates Coverage On Evommune with Buy Rating, Announces Price Target of $35

Benzinga·01/06/2026 11:56:28
Listen to the news
HC Wainwright & Co. analyst Mitchell S. Kapoor initiates coverage on Evommune (NYSE:EVMN) with a Buy rating and announces Price Target of $35.